Table 3

Prospective analysis

SCP VD	Global	Group 1	Group 2	Group 3	Control group
Central	p=0.143*	p=0.102*	p=0.835*	p=0.647*	p=0.147*
Inferior	p=0.065*	p=0.215*	p=0.073*	p=0.369*	p=0.094*
Superior	p= 0.105†	p=0.756*	p=0.230 *	p=0.616*	p=0.313 *
Nasal	p=0.714*	p=0.679*	p=0.375*	p=0.557*	p=0.117*
Temporal	p=0.612 *	p=0.619 *	p=0.58 *	p=0.811*	p=0.108*
FAZ area	p=0.181†	p=0.330†	p=0.141†	p=0.453†	p=0.082†

Significant values shown in bold.
Superficial plexus VD mean comparison at baseline and at 8-month examination.
*Wilcoxon signed rank test.
†Paired t-test.
FAZ, foveal avascular zone; SCP, superficial capillary plexus; VD, vessel density.